Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?
- 1 February 2001
- journal article
- clinical trial
- Published by Elsevier BV in Transplantation Proceedings
- Vol. 33 (1-2), 1461-1464
- https://doi.org/10.1016/s0041-1345(01)01906-6
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimusThe Journal of Heart and Lung Transplantation, 1999
- Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: importance of mycophenolic acid therapeutic drug monitoringThe Journal of Heart and Lung Transplantation, 1999
- Simvastatin Reduces Graft Vessel Disease and Mortality After Heart TransplantationCirculation, 1997
- Effect of Pravastatin on Outcomes after Cardiac TransplantationNew England Journal of Medicine, 1995
- A PROSPECTIVE RANDOMIZED TRIAL OF FK506 VERSUS CYCLOSPORINE AFTER HUMAN PULMONARY TRANSPLANTATION1Transplantation, 1994